Ponezumab - CISMeF

Preferred Label : Ponezumab;

NCIt synonyms : Anti-human beta-amyloid Monoclonal Antibody PF-04360365;

NCIt definition : A humanized monoclonal antibody (IgG2deltaA) raised against amyloid beta peptides with Alzheimer disease treatment application. Ponezumab recognizes and binds the free carboxy terminal amino acids 33-40 of the amyloid beta peptide 1-40 and may be used in a passive immunotherapy treatment.;

UNII : 1TG15H1XE9;

CAS number : 1178862-65-1;

Molecule name : PF-04360365; RN-1219;

Chemical formula : C6552H10158N1730O2090S52;

Details

Origin ID

C97941;

UMLS CUI

C3273712;

Currated CISMeF NLP mapping
- ponezumab [MeSH concept]
- ponezumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- ponezumab [MeSH Supplementary Concept]
- ponezumab [MeSH concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients